🔬
Foundation Sciences · Genetics
Gene Expression and Regulation
Gene expression is regulated at transcriptional, post-transcriptional, translational and post-translational levels by promoters, enhancers, transcription factors and non-coding RNAs.
📌 Learning Objectives
- Describe the underlying mechanism of Gene Expression and Regulation.
- Identify the key clinical features and complications of Gene Expression and Regulation.
- Outline the appropriate investigations and management of Gene Expression and Regulation.
- Discuss the implications for patients and families of Gene Expression and Regulation.
📋 Overview
RNA polymerase II transcribes mRNA; splicing removes introns; mRNA is translated by ribosomes. Dysregulation contributes to cancer, developmental disorders and many other diseases.
🔬 Basic Science
RNA polymerase II transcribes mRNA; splicing removes introns; mRNA is translated by ribosomes. Dysregulation contributes to cancer, developmental disorders and many other diseases.
🏥 Clinical Relevance
Mutations in regulatory elements (e.g. enhancers) can cause disease without altering coding sequence.
🧪 Investigations
Investigation depends on clinical context: relevant blood tests, imaging, and specific genetic or histopathological tests as appropriate. Refer to specialist services where indicated.
💊 Management
Management is condition-specific and typically multidisciplinary, combining medical therapy, surgical intervention where appropriate, supportive care, and family/genetic counselling.
Revision Resources – expand the sections below for high-yield notes, exam pearls, key facts and further reading.
MLA High-Yield Notes & Quick Revision ⌄
Common SBA themes: recognising the underlying mechanism, identifying classic clinical features, and choosing the first-line investigation or management step. Watch for inheritance pattern and characteristic associations.
gene expression
transcription
splicing
microrna
enhancer
- Promoters and enhancers regulate transcription initiation.
- Alternative splicing increases proteome diversity from a limited gene set.
- MicroRNAs bind to 3' UTRs to silence specific mRNAs.
- Mutations in splice sites can cause loss of function (e.g. β-thalassaemia, CF).
- Transcription factor mutations cause developmental syndromes (e.g. PAX6 in aniridia).
Exam Pearls ⌄
⭐ High Yield
Promoters and enhancers regulate transcription initiation.
Alternative splicing increases proteome diversity from a limited gene set.
MicroRNAs bind to 3' UTRs to silence specific mRNAs.
Mutations in splice sites can cause loss of function (e.g. β-thalassaemia, CF).
Transcription factor mutations cause developmental syndromes (e.g. PAX6 in aniridia).
💡 Clinical Pearl
Gene Expression: Mutations in regulatory elements (e.g. enhancers) can cause disease without altering coding sequence.
⚠️ Exam Tip — Common Mistakes
Confusing the mechanism of Gene Expression and Regulation with related conditions.
Missing classic clinical features of Gene Expression and Regulation in SBA stems.
Failing to consider Gene Expression and Regulation in the differential diagnosis.
Key Facts ⌄
Promoters and enhancers regulate transcription initiation.
Alternative splicing increases proteome diversity from a limited gene set.
MicroRNAs bind to 3' UTRs to silence specific mRNAs.
Mutations in splice sites can cause loss of function (e.g. β-thalassaemia, CF).
Transcription factor mutations cause developmental syndromes (e.g. PAX6 in aniridia).
Related Topics ⌄
References ⌄
- GMC MLA Content Map
- NICE Clinical Knowledge Summaries
- BMJ Best Practice
Further Resources
Medical Portfolio & Career Development
Build a professional portfolio website for applications, audits, teaching, research and career progression.
CVtoWebsite.com →